We are live on ! Find out more
ARRY

Array Biopharma Inc
ARRY

Delisted

ARRY was delisted on the 29th of July, 2019.

Back to rankings

133 hedge funds and large institutions have $1.05B invested in Array Biopharma Inc in 2015 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 55 increasing their positions, 35 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 15

79% more capital invested

Capital invested by funds: $586M → $1.05B (+$464M)

57% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 35

32% more call options, than puts

Call options by funds: $25.1M | Put options by funds: $19M

9% more funds holding

Funds holding: 122 → 133 (+11)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
133
Holders Change
+11
Holders Change %
+9.02%
% of All Funds
3.54%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
27
Increased
55
Reduced
35
Closed
15
Calls
$25.1M
Puts
$19M
Net Calls
+$6.1M
Net Calls Change
+$5.59M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$52.1M
2
BBA
Baker Bros. Advisors
New York
+$30.1M
3
O
OrbiMed
New York
+$14.1M
4
Invesco
Invesco
Georgia
+$12.9M
5
Millennium Management
Millennium Management
New York
+$11.9M

Top Sellers

1
BI
BVF Inc
California
-$16.8M
2
BA
BlackRock Advisors
Delaware
-$8.27M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$7.72M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$4.27M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$3.93M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$137M +$52.1M +7,315,521 +65%
RG
2
Redmile Group
California
$96.7M +$9.02M +1,267,300 +11%
DM
3
Deerfield Management
New York
$87.2M – – –
BI
4
BVF Inc
California
$69.3M -$16.8M -2,366,518 -20%
O
5
OrbiMed
New York
$68M +$14.1M +1,984,610 +27%
T. Rowe Price Associates
6
T. Rowe Price Associates
Maryland
$56.1M -$7.72M -1,085,000 -12%
BBA
7
Baker Bros. Advisors
New York
$41.7M +$30.1M +4,224,958 +295%
BFA
8
BlackRock Fund Advisors
California
$41.5M +$3.96M +555,868 +11%
State Street
9
State Street
Massachusetts
$35.9M +$214K +30,107 +0.6%
Vanguard Group
10
Vanguard Group
Pennsylvania
$35.6M +$3.17M +444,821 +10%
BIT
11
BlackRock Institutional Trust
California
$29.9M +$565K +79,429 +2%
PA
12
Pinnacle Associates
New York
$29.1M +$139K +19,515 +0.5%
TCM
13
TimesSquare Capital Management
New York
$28.1M -$2.03M -285,700 -7%
AG
14
Artal Group
Luxembourg
$27.3M +$5.05M +710,000 +24%
Millennium Management
15
Millennium Management
New York
$19M +$11.9M +1,672,260 +185%
Invesco
16
Invesco
Georgia
$13.4M +$12.9M +1,813,209 New
First Manhattan
17
First Manhattan
New York
$11.9M +$2.28M +320,000 +25%
Deutsche Bank
18
Deutsche Bank
Germany
$11.9M +$1.83M +256,822 +19%
AC
19
Apex Capital
California
$11.4M -$3.22M -452,700 -23%
Northern Trust
20
Northern Trust
Illinois
$10.8M +$577K +81,029 +6%
BIM
21
Bogle Investment Management
Massachusetts
$10.7M +$10.3M +1,450,173 New
RCM
22
RA Capital Management
Massachusetts
$10M +$9.66M +1,357,584 New
Renaissance Technologies
23
Renaissance Technologies
New York
$7.77M +$7.51M +1,054,652 New
Goldman Sachs
24
Goldman Sachs
New York
$7.46M +$5.65M +793,130 +362%
CNB
25
City National Bank
California
$7.27M +$1.73M +243,485 +33%
1
2 3 4 5

ARRY Hedge Fund Activity: Q1 2015 in Review

133 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Array Biopharma Inc (ARRY) for Q1 2015, worth a combined $1.05B — up 79% from $586M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new ARRY positions and 15 closed out — a net gain of 12 holders — while 55 added to existing stakes and 35 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $52.1M. The largest seller was BVF Inc, cutting an estimated $16.8M.

  • 133 institutional investors held Array Biopharma Inc (ARRY) as of Q1 2015, up from 122 in Q4 2014.
  • Funds reported $1.05B of Array Biopharma Inc stock for Q1 2015, up 79% quarter-over-quarter.
  • 27 funds opened new Array Biopharma Inc positions in Q1 2015 and 15 closed out, a net change of +12 holders.
  • The largest Array Biopharma Inc buyer in Q1 2015 was Fidelity Investments, an estimated $52.1M added.
  • The largest Array Biopharma Inc seller in Q1 2015 was BVF Inc, an estimated $16.8M sold.

Based on aggregated 13F filings for Q1 2015.